Table 1 Demographic and clinical characteristics of patients included in the tracing study (N = 724)
Parameter | Adults | Children |
|---|---|---|
Number (% of total) | 659 (91%) | 65 (9%) |
Age (median, IQR) | 36 (31-43) | 6 (3-10) |
Number (%) of females | 351 (53%) | 28 (43%) |
Year of ART start (median; range) | 2004 (2000-2005) | 2004 (2002-2005) |
ART free of charge at start (after 10 June 2004) | 440 (67%) | 52 (80%) |
CD4 at start of ART (median, IQR)* | 71 (22-141) | 184 (28-423) |
Reason ART start | ||
   Low CD4 count | 72 (11%) | 3 (5%) |
   WHO stage 3 | 444 (67%) | 58 (89%) |
   WHO stage 4 | 124 (19%) | 3 (5%) |
   Transfer in | 3 (0.5%) | 0 (0%) |
   Not recorded | 16 (2.5%) | 1 (1%) |
Days of follow up on ART (median, IQR) | 73 (14-303) | 92 (13-210) |
Number (%) by time period since start of ART | ||
   No follow-up | 109 (17%) | 13 (20%) |
   Months 1 to 6 | 331 (50%) | 32 (49%) |
   Months 7 to 12 | 78 (12%) | 12 (19%) |
   Months 13 or later | 141 (21%) | 8 (12%) |
Number (%) with telephone contact ☎ | 307 (47%) | 24 (37%) |
Residence in Lilongwe | 567 (86%) | 58 (89%) |